2 weeks Ago By ABMN Staff
Encompass Health Co. ( NYSE:EHC – Get Free Report ) declared a quarterly dividend on Wednesday, July 24th, Zacks reports. Investors of record on Tuesday, October 1st will be paid a dividend of 0.
17 per share on Tuesday, October 15th. This represents a $0.68 annualized dividend and a yield of 0.
71%. The ex-dividend date is Tuesday, October 1st. This is a boost from Encompass Health’s previous quarterly dividend of $0.
15. Encompass Health has decreased its dividend payment by an average of 18.8% per year over the last three years.
Encompass Health has a payout ratio of 14.6% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Encompass Health to earn $4.
63 per share next year, which means the company should continue to be able to cover its $0.68 annual dividend with an expected future payout ratio of 14.7%.
Encompass Health Price Performance EHC opened at $96.01 on Friday. The company has a debt-to-equity ratio of 1.
08, a current ratio of 1.35 and a quick ratio of 1.35.
The stock has a market capitalization of $9.67 billion, a P/E ratio of 25.95, a price-to-earnings-growth ratio of 1.
41 and a beta of 0.88. The company’s 50 day simple moving average is $91.
00 and its 200-day simple moving average is $85.98. Encompass Health has a one year low of $57.
55 and a one year high of $97.56. Encompass Health announced that its board has authorized a share buyback program on Wednesday, July 24th that allows the company to buyback $500.
00 million in shares. This buyback authorization allows the company to purchase up to 5.4% of its shares through open market purchases.
Shares buyback programs are usually an indication that the company’s board of directors believes its stock is undervalued. Wall Street Analysts Forecast Growth A number of equities analysts have issued reports on the stock. UBS Group raised their price objective on shares of Encompass Health from $100.
00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday. Truist Financial lifted their price objective on Encompass Health from $100.
00 to $104.00 and gave the stock a “buy” rating in a research note on Thursday, August 15th. Barclays cut their target price on Encompass Health from $113.
00 to $109.00 and set an “overweight” rating on the stock in a research note on Tuesday, August 6th. Royal Bank of Canada boosted their target price on Encompass Health from $95.
00 to $105.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Leerink Partnrs raised Encompass Health to a “strong-buy” rating in a research note on Wednesday, July 10th.
Nine research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $102.
88. Read Our Latest Analysis on Encompass Health Insider Buying and Selling In other Encompass Health news, CFO Douglas E. Coltharp sold 12,260 shares of Encompass Health stock in a transaction that occurred on Tuesday, August 13th.
The shares were sold at an average price of $86.34, for a total value of $1,058,528.40.
Following the transaction, the chief financial officer now owns 136,227 shares of the company’s stock, valued at $11,761,839.18. The sale was disclosed in a legal filing with the SEC, which is accessible through this link .
2.10% of the stock is owned by company insiders. Encompass Health Company Profile ( Get Free Report ) Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico.
It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. Further Reading Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.
com's FREE daily email newsletter ..
